Delivery Order SPE2DB25D3202-SPE2DB25FTBCL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $22,005.93 to AmerisourceBergen Drug Corp for the supply of Fingolimod 0.5 mg capsules (30-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Fingolimod is a disease-modifying therapy used in the treatment of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fingolimod 0.5 mg capsules (30-count units) with a ceiling value of $1,497.86. This competitive, non-set-aside award was executed on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizing firm fixed-price pricing. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Fingolimod 0.5 mg capsules (30-count units) with a contract ceiling value of $4,110.39. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 27, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fingolimod 0.5 mg capsules (30-count units) with a ceiling value of $9,867.80 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $17,530.56 to AmerisourceBergen Drug Corp for the supply of Fingolimod 0.5 mg capsules (30-count packaging). This is a firm fixed price, competitively awarded contract with no set-aside designation, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is scheduled for completion by September 4, 2025, just one day after the award date of September 3, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fingolimod 0.5 mg capsules (30-count) with a ceiling value of $60,526.11. This is a firm fixed price, non-competitive delivery order that was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Fingolimod is a disease-modifying therapy used in the treatment of multiple...
- The Defense Logistics Agency awarded a $10,360.75 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fingolimod 0.5 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fingolimod 0.5 mg capsules (30-count units) under a firm fixed price contract valued at $30,185.00. The contract, awarded June 18, 2025, with completion targeted for June 20, 2025, represents a non-competitive set-aside award utilizing standard competitive procedures. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform all...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $18,047.16 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of fingolimod 0.5 mg capsules and has an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 that Amerisourcebergen holds with DLA Troop Support Medical for...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order valued at $34,567.53 by the Defense Logistics Agency's Medical Supply Chain division on September 13, 2025, for the supply of Fingolimod 0.5mg tablets in a 30-count quantity. The award is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 9, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTBCLDelivery Order
The Defense Logistics Agency awarded a $5,394.00 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fingolimod 0.5 mg capsules (30-count packages). This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The award was made on a firm fixed-price basis with no set-aside designation, reflecting open competitive procurement. The ultimate completion date is set for August 8, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. Fingolimod is a selective sphingosine-1-phosphate receptor modulator used in the treatment of multiple sclerosis and represents the type of specialized neurological medication that AmerisourceBergen routinely supplies to support military and federal healthcare systems. This delivery order exemplifies the company's role as a critical pharmaceutical distributor within the Defense Health Agency supply chain, delivering prescription medications across multiple therapeutic domains to support military medical readiness and veteran healthcare initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 8/7/25 |